Pfizer to close two manufacturing plants in India
By 
Kit Chapman2019-01-16T14:29:00
Closures will lead to the loss of 1700 jobs – almost 6% of the pharma giant’s manufacturing workforce
Pfizer has announced its IKKT and Aurangabad plants in India will close ‘as soon as possible in 2019’ in a move affecting almost 6% of its manufacturing workforce. The two sites have already ceased production, Pfizer confirmed, after a review found the sites were ‘not viable’ following ‘very significant long term loss of product demand’. IKKT, near Chennai, accounts for around 1000 employees in Pfizer’s 30,000-strong global manufacturing staff, with a further 700 in Aurangabad.